Identification of Novel HSP90 alpha / beta Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration of Potential Utility in Treating CNS Disorders such as Huntington's Disease.
PDB-4o04: Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease 手法: X-RAY DIFFRACTION / 解像度: 1.82 Å
PDB-4o05: Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease 手法: X-RAY DIFFRACTION / 解像度: 1.79 Å
PDB-4o07: Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease 手法: X-RAY DIFFRACTION / 解像度: 1.86 Å
PDB-4o09: Identification of novel HSP90 / isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington s disease 手法: X-RAY DIFFRACTION / 解像度: 1.96 Å
PDB-4o0b: Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease 手法: X-RAY DIFFRACTION / 解像度: 1.93 Å